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Available online 15 October 2012AbstractThe type II variant of Kounis syndrome is defined as a rare allergic myocardial angina or infarction event in patients with preexisting
quiescent coronary artery disease. Various causative factors have been implicated in the etiology of Kounis syndrome. However, reports
highlighting the importance of recognizing a decreased preload caused by allergic right ventricular (RV) myocardial infarction and subsequent
cardiogenic shock from ongoing anaphylactic shock are rare. Here we report the case of a 54-year-old male who initially presented with
anaphylactic shock after ingesting onions. His condition silently progressed to RV infarction and cardiogenic shock within 2 hours of symptom
onset. Under such instances, it is crucial to promptly identify RV infarction and cardiogenic shock by repeatedly performing electrocardiography
at frequent intervals.
Copyright  2012, Taiwan Society of Emergency Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
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The type II variant of Kounis syndrome is defined as a rare,
irreversible, allergic myocardial angina or myocardial infarc-
tion (MI) event in patients with preexisting quiescent coronary
artery disease (CAD). In cases where the allergic myocardial
injury involves the right coronary artery, subsequent occur-
rence of sudden cardiogenic shock is possible. Management of
anaphylactic shock differs from that of MIdthe former
requires massive fluid resuscitation along with anti-allergen
and vasopressor therapy, whereas the latter when accompa-
nied with subsequent cardiogenic shock requires emergency
percutaneous coronary intervention and intra-aortic balloon
pump (IABP) implantation to maintain hemodynamic stability.
Determining the cause of hemodynamic instability in patients* Corresponding author. No. 145, Zhengzhou Road, Datong District, Taipei
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2211-5587/$ - see front matter Copyright  2012, Taiwan Society of Emergency
http://dx.doi.org/10.1016/j.jacme.2012.08.002with type II Kounis syndrome is challenging for even the most
seasoned clinician, and inaccurate or delayed management
may lead to fatal outcomes.
2. Case report
A 54-year-old man of medium build (170 cm in height,
88 kg in weight) presented at the emergency department of our
institution with dizziness, weakness, chest tightness, and
generalized pruritus with skin erythema. All these symptoms
occurred in approximately 20 minutes after he ate onions at
dinner. His medical history revealed hypertension, CAD, and
anterior MI, for which he had undergone coronary artery
bypass graft surgery 2 years earlier. In addition, he was known
to be allergic to onions, green onions, and garlic. However, the
previous allergic events had been mild and resolved soon after
the intake of oral fexofenadine hydrochloride (Allegra).
On initial examination, his initial vital signs were as
follows: body temperature, 37C; heart rate, 55 beats per
minute (bpm); respiratory rate, 20 bpm; and blood pressure,Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
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and listless but alert. Urticaria and increased temperature was
observed all over his face, trunk, and extremities. Chest
auscultation did not indicate stridor, wheezing, or basal
crackles. Based on a presumed diagnosis of anaphylactic
shock, oxygen was supplied via a mask at 8 L/min; in addition,
fluid resuscitation, intravenous diphenhydramine, methyl-
prednisolone, and ranitidine were immediately administered.
Epinephrine was withheld considering the patient’s cardio-
vascular history and the associated risk of adverse events,
namely, epinephrine-induced vasospasm or MI. Initial elec-
trocardiography (ECG) revealed first-degree atrioventricular
block and right bundle branch block that was consistent with
an ECG finding obtained 3 years earlier (Fig. 1).
Chest X-ray revealed mild symmetric infiltrates with
borderline cardiomegaly. Laboratory data indicated leukocy-
tosis (16,800/mL) with a normal differential count and an
eosinophil count of 0.4%. The glutamate oxaloacetate trans-
aminase level was 26 U/L (5e35 U/L). Initial cardiac enzyme
levels measured within 70 minutes after onion exposure were
within the normal range as follows: creatine kinase (CK),
134 U/L (39e308 U/L); CK-MB, 21 U/L (7e25 U/L); and
troponin I, 0.086 mg/L (0e0.5 mg/L).
The patient remained hypotensive (89/51 mmHg) even
after 2.5 L of normal saline fluid administration. Central
venous catheterization was then performed to maintain
hemodynamic stability, and the initial pressure was high
(28 cm H2O). Although the generalized skin rash disappeared,
the patient continued to complain of progressive chest
compression without radiation to any body parts. ECG ob-
tained 2 hours after the allergic event revealed ST-segment
elevation in leads II, III, and aVF (Fig. 2). Cardiac enzyme
levels at this point were as follows: CK, 550 U/L; CKMB,
104 U/L; troponin-I, 1.926 mg/L. There was no significant ST-
segment elevation in lead V4R on a right-sided ECG. Acute
ST-segment elevation with inferior wall MI was diagnosed,
and primary cardiac intervention was performed immediately.Fig. 1. Initial electrocardiography (ECG) showed no intervConsidering that anaphylaxis may not have been the only
component of shock, continuous infusions of norepinephrine
and dopamine were administered for the management of
strongly suspected cardiogenic shock. With this treatment, the
patient’s blood pressure was maintained at 119/69 mmHg,
with a heart rate of 104 bpm. Aspirin (300 mg) and clopi-
dogrel (400 mg) were administered in combination with
continuous heparin infusion before primary catheterization.
Morphine was not used to avoid mast cell activation and
additional histamine release.
Selective cardiac angiography revealed total occlusion of
the distal right coronary artery. Angioplasty using a voyager
balloon was successfully performed (Fig. 3). The saphenous
vein graft was patent to the diagonal branch and the obtuse
marginal branch, whereas the left internal mammary artery
graft was patent to the left anterior descending artery. An
IABP was implanted and set at a rate of 1:1. A temporary
pacemaker was also inserted and set at 60 bpm for the
management of cardiogenic shock. In addition, intravenous
antihistamine and hydrocortisone were regularly administered
during admission.
CK (7257 U/L) and CK-MB (551 U/L) levels peaked
approximately 7 hours after catheterization, and ECG revealed
a Q wave in the inferior lead (Fig. 4). Two days after the
primary cardiac intervention, the IABP and temporary pace-
maker were removed under continuous infusion of dobut-
amine. ECG performed 2 days later revealed a marked
decrease in left ventricular ejection fraction (39%) and poor
left ventricular contractility, with posterior and apical wall
hypokinesis. The patient was transferred to the general ward
on the 3rd hospital day because of a relatively stable hemo-
dynamic state. However, he developed fever, dyspnea, and
productive cough the following day, and nosocomial pneu-
monia was diagnosed. Three days after piperacillin/tazo-
bactam treatment, i.e., on the 7th hospital day, the patient took
discharge against the physicians’ advice with a prescription of
oral antibiotic therapy.al change compared to the last ECG three years ago.
Fig. 2. Two and a half hours later, repeated ECG exhibited II, III, aVF ST-segment elevation myocardial infarction.
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Diverse allergic agents responsible for Kounis syndrome
have been reported in the literature, including nonsteroidal
anti-inflammatory drugs, antibiotics, proton pump inhibitors,
muscle relaxants, chemotherapeutic agents, drug-eluting
stents, insect stings, shellfish ingestion, tetanus immuniza-
tion, and venoms.1e7 Although allergic angina proves to be
only vasospasms in a majority of cases, and primary cathe-
terizations show no significant stenosis, type II Kounis
syndrome involves the occurrence of true MIs that are capable
of presenting as cardiogenic shock and lethal dysrhythmias.
For a patient with a preexisting history of quiescent CAD,
a tiny atherosclerotic plaque rupture may cause a significant
MI event.7 Such an event may occur any minute after an
anaphylactic reaction has initiated.
Morphine sulfate is prescribed as adjunctive therapy in
patients with acute coronary syndrome; however, it may cause
histamine release by activating mast cells and may not be
suitable for the management of allergic MI.8,9 Epinephrine, on
the other hand, is considered as an essential treatment to
reverse anaphylactic effects. However, serious adverse effects,Fig. 3. Before: selective cardiac angiography revealed RCA total occlusion;including coronary spasm and MI, are also reported to be
directly related to epinephrine.10e13 Epinephrine is a potent
vasoconstrictor that can maintain systemic vascular resistance
during anaphylactic shock; however, this property may also
induce coronary vasospasm and myocardial injury. Although
epinephrine is considered as the first-line treatment for
anaphylactic shock, its benefit in patients with allergic MI is
controversial.
Chest tightness is considered a symptom of an allergic
reaction.14 ECG may be performed routinely in patients who
present with chest discomfort, unstable hemodynamics, or
preexisting cardiovascular disease. In our case, after desensi-
tizing management, persistent chest pain and hypotension
raised a suspicion of acute coronary syndrome. A single ECG
was apparently not sufficient to detect this evolution; there-
fore, repeated ECG performance within short intervals of time
was essential. On the basis of the rapid evolution of allergic
angina to true ST-segment MI in this case, we suggested
following the Joint Classification Committee/American Heart
Association guidelines for patients presenting with allergic
reactions and persistent chest discomfort, particularly for those
with a preexisting history of cardiovascular disease.15after voyager balloon angioplasty, RCA gained perfusion successfully.
Fig. 4. Post-PCI ECG showed Q wave in inferior lead.
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allergic MI evolved rapidly after exposure to the allergen;
furthermore, initial ECG and cardiac marker analysis at
presentation were not definitive. The risk of new-onset allergic
MI should be highlighted in patients with significant cardio-
vascular compromise even if initial screening tests are nega-
tive. Lethal cardiogenic shock or dysrhythmias may be
overlooked if anaphylactic shock is considered the sole basis
for treatment.
4. Conclusion
In conclusion, when a patient with anaphylactic shock
presents to the emergency department with profound shock or
persistent chest pain despite desensitizing management,
repeating ECG and cardiac marker analysis at short intervals
of time are important to ensure that acute coronary syndrome
does not occur simultaneously.
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